Beginning Development of Integrated System Between STiV and Quality Designer for GxP

New Integrated System Development

Introduction

Taiyo Holdings Corporation, headquartered in Toshima, Tokyo, has made strides in enhancing pharmaceutical processes through technology. Their subsidiary, Funlead, which specializes in ICT services, has recently announced the initiation of a collaboration between its generative AI platform, STiV, and the quality management system, Quality Designer for GxP, developed by UnionSync, located in Osaka. This partnership aims to enhance the effectiveness of quality management within the pharmaceutical sector.

Understanding the Systems

Quality Designer for GxP is designed to digitize and centralize information related to quality management processes, including complaint management, deviation management, and change control in the manufacturing of pharmaceuticals and medical devices. The system aids in ensuring data integrity and preventing data tampering, which is critical in an industry governed by strict regulatory standards like GxP.

However, even with careful documentation, pharmaceutical companies have faced challenges in quickly retrieving necessary information due to the vast volumes of paperwork accumulated over time. The reliance on historical deviation records and CAPA (Corrective and Preventive Actions) has led to impediments in decision-making and increased investigation time.

Advancements through Collaboration

The integration of STiV with Quality Designer for GxP allows for direct access to high-quality management data stored within the latter. This partnership, leveraging STiV's powerful generative AI and cross-search capabilities, is set to transform how pharmaceutical companies utilize past insights. Here are the key benefits of this integration:

1. Instant Search and Analysis

Utilizing AI, the system can promptly extract similar cases from a substantial database of past anomalies and CAPA information, facilitating rapid, informed decisions rather than relying solely on veteran experiences.

2. Streamlined Document Creation

STiV will assist in drafting new documents based on prior inquiries and corrective measures, enhancing consistency in documentation quality across the organization.

3. Knowledge Accessibility

By resolving situations where employees are unsure of whom to approach for information, the integration sets up an environment where anyone can access the company's wisdom simply through STiV.

Upcoming Demonstrations

An upcoming opportunity to see the integration in action will take place at the INTERPHEX Week Tokyo 2026, scheduled from May 20-22 at Makuhari Messe. Funlead will be presenting demonstrations of the integration features at their booth, enabling visitors to visualize the practical applications of generative AI within pharmaceutical operations.

Event Details

- Exhibition Name: INTERPHEX Week Tokyo 2026 (2nd Pharma DX Expo Tokyo)
- Dates: May 20-22, 2026
- Location: Makuhari Messe
- Booth Number: 19-5

Conclusion

The STiV platform was developed as a solution for the challenges encountered by the pharmaceutical sector under Taiyo Holdings. It focuses on overcoming knowledge silos and fostering productivity through advanced technologies like generative AI. STiV enhances knowledge sharing and technological transfer across organizations, making it invaluable for those in medically critical industries.

Through this partnership with UnionSync, Taiyo Holdings and Funlead are poised to redefine quality management in pharmaceuticals, ensuring that information is readily accessible and actionable for quicker decisions and improved operational efficiency.

About Taiyo Holdings and Funlead

Taiyo Holdings holds the position of being the leading company in the global market for solder resist, a protective insulating material used in printed circuit boards. The company is deeply involved in the development and manufacturing of electronic component chemical materials as well as pharmaceuticals. Funlead supports digital transformation efforts, focusing on the manufacturing and pharmaceutical industries by providing comprehensive IT solutions.

For more information: